Federal contract award

75A50122C00046

ABBOTT: TO CONDUCT CLINICAL TRAINING AND VALIDATION STUDIES TO SUPPORT A FUTURE FDA MARKETING APPLICATION WITH AN EXPANDED INDICATION FOR USE OF THE ABBOTT TBI TEST ? TO AID IN THE DIAGNOSIS OF TRAUMATIC BRAIN INJURY IN ADULTS AND PEDIATRIC PATIENTS.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$65.5M
Current contract value$65.5M
Potential contract value / ceiling$83.7M
Start dateSep 21, 2022
Current end dateNov 15, 2029
Potential end dateNov 15, 2029
Latest award activityMar 19, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Mar 19, 2026P00008$21.0MEXERCISE CLIN 0004 OPTION PERIOD 1 AND REVISE THE POP TO 3/23/26-11/15/29. REVISE THE TASKS IN CLIN 0006 OF THE SOW.
Jul 24, 2025P00007$18.9MEXERCISE CLIN 006 OPTION PERIOD 3, SUPPLEMENTAL FUNDING FOR CLIN 0003 AND ADMINISTRATIVE REVISIONS.
Apr 1, 2025P00006$0THE PURPOSE OF THIS NO-COST MODIFICATION IS TO A) REVISE PART II SECTION I CONTRACT CLAUSES I.3 ADDITIONAL CONTRACT CLAUSES, I.3.1 ADDITIONAL FEDERAL ACQUISITION REGULATION (FAR) (48 CFR 1) CLAUSES IN FULL TEXT AS FOLLOWS: 1) INCORPORATE FAR 52.
May 13, 2024P00005$0NO-COST MOD TO ADD LANGUAGE TO THE ADVANCE UNDERSTANDING SECTION B.3.11. MODIFICATIONS TO PERIODS OF PERFORMANCE, MILESTONES, AND DELIVERABLES AND REVISE THE STATEMENT OF WORK.
Sep 8, 2023P00004$0NO-COST MOD TO REVISE BASE PERIOD POPS, REVISE ADVANCE UNDERSTANDINGS, ADD CERTIFICATE OF CONFIDENTIALITY, ADD FAR CLAUSE 52.204-27.
Mar 23, 2023P00003$0REVISE SECTION F.3.2(G) OTHER REQUIREMENTS/DELIVERABLES SECURITY PLAN.
Feb 3, 2023P00002$0REVISE THE TIN NUMBER TO MATCH THE UEI, AND ORGANIZATIONS ADDRESS AND REVISE THE DELIVERABLE TABLE IN SECTION F.2.
Nov 21, 2022P00001$0NO-COST, BILATERAL MODIFICATION IS TO REVISE SECTION G.3 KEY PERSONNEL AND SECTION I1. FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES. ADDITIONALLY ABBOTT LABORATORIES UEI TAX ID NUMBER IS HEREBY UPDATED FROM 36-4184946 TO 36-0698440
Sep 21, 20220$25.6MABBOTT: TO CONDUCT CLINICAL TRAINING AND VALIDATION STUDIES TO SUPPORT A FUTURE FDA MARKETING APPLICATION WITH AN EXPANDED INDICATION FOR USE OF THE ABBOTT TBI TEST ? TO AID IN THE DIAGNOSIS OF TRAUMATIC BRAIN INJURY IN ADULTS AND PEDIATRIC PATIENTS.

Estimated positioning window

Nov 15, 2028 – May 15, 2029

Recompete signal:
40/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 40/100. Available recorded signals: 35 points.

Contract end 2029-11-15 (1117 days from calculation)
+5 points
121 historical awards in this buyer and category group
+15 points
9 recorded award transactions
+10 points
Latest award action: 2026-03-19
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+0 points
Linked official forecast
+0 points
Calculated on
2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.